Literature DB >> 11874959

Can we predict type 1 diabetes in the general population?

Mikael Knip.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11874959     DOI： 10.2337/diacare.25.3.623

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

1.  Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.

Authors:  Mikael Knip; Hans K Åkerblom; Eva Al Taji; Dorothy Becker; Jan Bruining; Luis Castano; Thomas Danne; Carine de Beaufort; Hans-Michael Dosch; John Dupre; William D Fraser; Neville Howard; Jorma Ilonen; Daniel Konrad; Olga Kordonouri; Jeffrey P Krischer; Margaret L Lawson; Johnny Ludvigsson; Laszlo Madacsy; Jeffrey L Mahon; Anne Ormisson; Jerry P Palmer; Paolo Pozzilli; Erkki Savilahti; Manuel Serrano-Rios; Marco Songini; Shayne Taback; Outi Vaarala; Neil H White; Suvi M Virtanen; Renata Wasikowa
Journal:  JAMA       Date:  2018-01-02       Impact factor: 56.272

2.  Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes.

Authors:  S M Virtanen; M G Kenward; M Erkkola; S Kautiainen; C Kronberg-Kippilä; T Hakulinen; S Ahonen; L Uusitalo; S Niinistö; R Veijola; O Simell; J Ilonen; M Knip
Journal:  Diabetologia       Date:  2006-04-05       Impact factor: 10.122

3.  Dietary intervention in infancy and later signs of beta-cell autoimmunity.

Authors:  Mikael Knip; Suvi M Virtanen; Karri Seppä; Jorma Ilonen; Erkki Savilahti; Outi Vaarala; Antti Reunanen; Kari Teramo; Anu-Maaria Hämäläinen; Johanna Paronen; Hans-Michael Dosch; Timo Hakulinen; Hans K Akerblom
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

4.  Prediction of type 1 diabetes in the general population.

Authors:  Mikael Knip; Sari Korhonen; Petri Kulmala; Riitta Veijola; Antti Reunanen; Olli T Raitakari; Jorma Viikari; Hans K Akerblom
Journal:  Diabetes Care       Date:  2010-06       Impact factor: 19.112

5.  Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

Authors:  Mikael Knip; Hans K Åkerblom; Dorothy Becker; Hans-Michael Dosch; John Dupre; William Fraser; Neville Howard; Jorma Ilonen; Jeffrey P Krischer; Olga Kordonouri; Margaret L Lawson; Jerry P Palmer; Erkki Savilahti; Outi Vaarala; Suvi M Virtanen
Journal:  JAMA       Date:  2014-06-11       Impact factor: 56.272

6.  Novel prokaryotic expression of thioredoxin-fused insulinoma associated protein tyrosine phosphatase 2 (IA-2), its characterization and immunodiagnostic application.

Authors:  Luciano Lucas Guerra; Natalia Inés Faccinetti; Aldana Trabucchi; Bruno David Rovitto; Adriana Victoria Sabljic; Edgardo Poskus; Ruben Francisco Iacono; Silvina Noemí Valdez
Journal:  BMC Biotechnol       Date:  2016-11-24       Impact factor: 2.563
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.